Akebia Therapeutics (AKBA) Goodwill & Intangibles (2018 - 2026)

Akebia Therapeutics (AKBA) has 9 years of Goodwill & Intangibles data on file, last reported at $59.0 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $59.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.0 million (changed 0.0% YoY), and the FY2025 annual result was $59.0 million, changed 0.0% from the prior year.
• Goodwill & Intangibles was little changed at $59.0 million in Q1 2026 per AKBA's latest filing, from $59.0 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $158.2 million in Q1 2022 and troughed at $59.0 million in Q4 2024.
• A 5-year average of $94.0 million and a median of $86.0 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles sank 37.95% in 2024, then changed 0.0% in 2025.
• A 5-year view of Goodwill & Intangibles shows it stood at $131.1 million in 2022, then fell by 27.49% to $95.1 million in 2023, then slumped by 37.95% to $59.0 million in 2024, then changed by 0.0% to $59.0 million in 2025, then changed by 0.0% to $59.0 million in 2026.
• Business Quant data shows AKBA's Goodwill & Intangibles at $59.0 million in Q1 2026, $59.0 million in Q4 2025, and $59.0 million in Q3 2025.